| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5615712 | The Journal of Heart and Lung Transplantation | 2017 | 25 Pages |
Abstract
Sirolimus was used in less than 10% of patients at 1 year post-transplant. Overall outcomes of sirolimus treated and non-treated patients were similar with respect to survival and major transplant adverse events. Further study of sirolimus in pediatric heart transplant patients is needed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Joseph W. MD, John L. MD, Elfriede MD, David C. PhD, Elizabeth MSPH, Kathy MPH, William J. MD, Richard MD, Gerard MD, William T. MD,